会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • NOVEL ENCAPSULATION OF FLUORESCENT, PHOTO-SENSITIVE, OR OXYGEN-SENSITIVE ACTIVE INGREDIENT FOR TOPICAL APPLICATION
    • 用于局部应用的荧光,光敏性或氧气敏感性成分的新颖包封
    • US20160287615A1
    • 2016-10-06
    • US15090595
    • 2016-04-04
    • BioPharmX, Inc.
    • Kin F. ChanAnja B. KrammerDouglas W. Thomas
    • A61K31/65A61K9/50A61K31/66A61K9/00
    • A61K31/65A61K9/14
    • A topical composition for treatment of a skin condition comprising a fluorescent, photosensitive, or oxygen sensitive active ingredient encapsulated in a plurality of tubular microparticles for pharmaceutical use in humans is described. Some embodiments comprise a topical composition for treatment of acne that comprises an encapsulation of a tetracycline class drug, such as crystalline minocycline, in a plurality of microparticles, wherein the microparticles comprise a divalent cation, such as Mg2+ or Zn2+. The tubular microparticles may comprise Mg2CO3. Benefits of various embodiments include the lack of visible fluorescence from a fluorescent active ingredient, reduced UV degradation of a photosensitive active ingredient, reduced UV degradation of an oxygen sensitive active ingredient, sun protection factor for the skin, and sustained delivery of a therapeutic dose.
    • 描述了用于治疗皮肤病症的局部组合物,其包含包封在用于人类药物的多个管状微粒中的荧光,感光或氧敏感性活性成分。 一些实施方案包括用于治疗痤疮的局部组合物,其包含将四环素类药物如结晶米诺环素包封在多个微粒中,其中所述微粒包含二价阳离子,例如Mg 2+或Zn 2+。 管状微粒可以包含Mg 2 CO 3。 各种实施方案的优点包括缺乏来自荧光活性成分的可见荧光,光敏活性成分的UV降解降低,氧敏感性成分的UV降解,皮肤的防晒因子和治疗剂量的持续递送。